𝔖 Bobbio Scriptorium

✦ LIBER ✦

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis

✍ Scribed by Gail L. Torkildsen; Mark B. Abelson; Paul J. Gomes

Book ID: 117321838
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 737 KB
Volume: 30
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(08)80051-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-masked, placebo-contr

Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model

✍ Peter A. D'Arienzo; Andrea Leonardi; George Bensch 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Comparison of ketotifen fumarate ophthal

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial

✍ H.Jerome Crampton 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 917 KB

Time to onset and duration of action of

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children

✍ Mark B. Abelson; Gail L. Torkildsen; Jon I. Williams; James A. Gow; Paul J. Gome 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A comparison of the relative clinical ef

A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model

✍ H. Jerome Cramptom 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 644 KB

A Single-Center, Double Masked, Randomiz

A Single-Center, Double Masked, Randomized, Placebo Controlled Study to Evaluate the Efficacy of Multiple Doses of 10 mg Montelukast Sodium (Singulair®) on the Signs and Symptoms of Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model

✍ Gomes, P.J.; Abelson, M.B. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB